The objective of this study was to quantify the economic utility in Romosinuano production systems by developing a bioeconomic model assumed cow-calf, cow-calf plus stocker (CCPS), and complete cycle operations. Each system produced males for sale and females for replacement. Input parameters were established from breed data collected by AGROSAVIA. Revenues were estimated using the official cattle price, and production costs were quantified per activity. In the results, for cow-calf operations, the maximum economic utility was 244.12 USD. CCPS, yielded 231.86 USD, and Complete cycle, 268.94 USD. The genetic progress per generation for W240, W480, W24 and CI was + 3.8 kg, + 5 kg, + 5.9 kg, and -1 d, respectively. The price of livestock was the sensitized variable with the greatest impact on maximum economic utility (± 118.64 USD to ± 155.44 USD), followed by mineral supplementation (16.31 USD to ± 37.34 USD). The sensitized variables with the lowest impact were food (± 1.62 USD to ± 1.8 USD) and health plan supplies (± 6.03 USD to ± 9.13 USD). It is concluded that economic utility defined as a composite trait influenced by the characteristics that shape it favors genetic progress and the identification of animals with optimal performance in different bovine production systems.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11602811 | PMC |
| http://dx.doi.org/10.1007/s11250-024-04066-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Advancing precision cancer immunotherapy drug development, administration, and response prediction with AI-enabled Raman spectroscopy.
Front Immunol
January 2025
Department of Surgery, Stanford School of Medicine, Stanford University Medical Center, Stanford, CA, United States.
Molecular characterization of tumors is essential to identify predictive biomarkers that inform treatment decisions and improve precision immunotherapy development and administration. However, challenges such as the heterogeneity of tumors and patient responses, limited efficacy of current biomarkers, and the predominant reliance on single-omics data, have hindered advances in accurately predicting treatment outcomes. Standard therapy generally applies a "one size fits all" approach, which not only provides ineffective or limited responses, but also an increased risk of off-target toxicities and acceleration of resistance mechanisms or adverse effects.
View Article and Find Full Text PDFPerceived benefits, costs, and relationships on provincial doctors' inclination to participate in urban-rural medical consortia in Central China: a social exchange theory perspective.
Front Public Health
January 2025
The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Objective: This study aims to investigate the perceived benefits, costs, and relationships that influence doctors' inclination to participate in urban-rural medical consortia (URMC). Furthermore, the study analyzes how perceived relationships moderate the impact of perceived benefits and costs on the inclination to take part in URMC.
Methods: The study was conducted between September 2022 and June 2023 utilizing an online survey in Henan Province, Central China, which included 749 respondents from provincial hospitals.
A comparative study of hospitalization costs of TKA inpatients before and after National Volume-based Procurement in Guangdong, China: an interrupted time-series analysis.
Front Public Health
January 2025
School of Health Management, Southern Medical University, Guangzhou, China.
Background: This study aims to explore the impact of the National Volume-based Procurement Policy in Guangdong Province on hospitalization costs for total knee arthroplasty inpatients.
Methods: Interrupted time-series analysis were used to examine the expenses associated with total knee arthroplasty for inpatients at a hospital in Guangzhou between May 10, 2021, and December 26, 2023. The period was divided into two phases based on the implementation of the policy, the pre-policy phase (May 10, 2021, to April 30, 2022) and the post-policy phase (May 1, 2022, to December 26, 2023).
The economic burden of atopic dermatitis in Romania: a broad perspective.
Front Public Health
January 2025
Dermatology Department, Colentina Clinical Hospital, Bucharest, Romania.
Introduction: Atopic dermatitis (AD), a common dermatological condition, is often associated with significant economic and social burdens. Despite extensive studies globally, there is a gap in understanding the impact of this condition in Romania. This study evaluated the economic burden of AD in Romania, considering both direct and indirect costs.
View Article and Find Full Text PDFImpact of crop commercialization on multidimensional poverty in rural Ethiopia: propensity score approach.
Front Public Health
January 2025
Department of Statistics, College of Science, Bahir Dar University, Bahir Dar, Ethiopia.
Introduction: Reducing poverty through crop commercialization is one of the antipoverty efforts that helps promote health. This study explored the prevalence and the causal relationship between crop commercialization and rural Ethiopian households' multidimensional poverty using multilevel data.
Methods: The study uses data from the most recent nationally representative Ethiopian socioeconomic survey 2018/19 to calculate the rural multidimensional poverty index using the Alkire and Foster technique.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!